A Phase II Study of Abraxane, Avastin and Gemcitabine for First Line Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs Paclitaxel (Primary) ; Bevacizumab; Gemcitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Jun 2011 Interim results were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
- 09 Dec 2008 Status changed from recruiting to active, no longer recruiting.